2 ms·

Fluvoxamine vs. Placebo and Clinical Deterioration in Outpatients with Covid-19

• menomatter 6y ago
  "Conclusions and Relevance In this preliminary study of adult outpatients with symptomatic COVID-19, patients treated with fluvoxamine, compared with placebo, had a lower likelihood of clinical deterioration over 15 days. However, the study is limited by a small sample size and short follow-up duration, and determination of clinical efficacy would require larger randomized trials with more definitive outcome measures."